Herti Trastuzumab for injection 440 mg

About Herti Trastuzumab for injection 440 mg

Herti Trastuzumab 440 mg Injection is a monoclonal antibody used in the treatment of HER2-positive breast cancer and gastric cancer. It works by specifically targeting the HER2 receptor present on cancer cells, thereby inhibiting tumor growth and promoting immune-mediated destruction of cancer cells.

This injection is widely used in oncology treatment protocols and is administered under strict medical supervision by trained healthcare professionals. Herti Trastuzumab is formulated to meet high quality and safety standards, ensuring reliable therapeutic effectiveness.

Key Benefits:

• Effective treatment for HER2-positive cancers

• Targeted therapy with proven clinical outcomes

• Helps slow or stop the growth of cancer cells

• Suitable for use in combination with chemotherapy

Indications:

• HER2-positive breast cancer

• HER2-positive metastatic gastric or gastroesophageal junction cancer

Dosage & Administration:
Dosage and schedule should be determined by an oncologist based on patient condition, body weight, and treatment protocol. Administered via intravenous infusion.

Storage Instructions:

• Store in a refrigerator at 2C to 8C

• Do not freeze

• Protect from light

Safety Information:

• For prescription use only

• Not to be self-administered

• Read the package insert carefully before use